227 related articles for article (PubMed ID: 31685458)
1. What's Old Is New Again: Bacteriophage Therapy in the 21st Century.
Aslam S; Schooley RT
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685458
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa.
Tkhilaishvili T; Winkler T; Müller M; Perka C; Trampuz A
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31527029
[TBL] [Abstract][Full Text] [Related]
3. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
[TBL] [Abstract][Full Text] [Related]
4. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient.
Law N; Logan C; Yung G; Furr CL; Lehman SM; Morales S; Rosas F; Gaidamaka A; Bilinsky I; Grint P; Schooley RT; Aslam S
Infection; 2019 Aug; 47(4):665-668. PubMed ID: 31102236
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.
Abd El-Aziz AM; Elgaml A; Ali YM
J Infect Dis; 2019 Apr; 219(9):1439-1447. PubMed ID: 30476337
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage therapy as a treatment option for transplant infections.
Aslam S
Curr Opin Infect Dis; 2020 Aug; 33(4):298-303. PubMed ID: 32657966
[TBL] [Abstract][Full Text] [Related]
8. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
9. Successful phage-antibiotic therapy of
Braunstein R; Hubanic G; Yerushalmy O; Oren-Alkalay S; Rimon A; Coppenhagen-Glazer S; Niv O; Marom H; Barsheshet A; Hazan R
Vet Q; 2024 Dec; 44(1):1-9. PubMed ID: 38726795
[TBL] [Abstract][Full Text] [Related]
10. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
Köhler T; Luscher A; Falconnet L; Resch G; McBride R; Mai QA; Simonin JL; Chanson M; Maco B; Galiotto R; Riat A; Civic N; Docquier M; McCallin S; Chan B; van Delden C
Nat Commun; 2023 Jun; 14(1):3629. PubMed ID: 37369702
[TBL] [Abstract][Full Text] [Related]
11. Fluctuating Bacteriophage-induced galU Deficiency Region is Involved in Trade-off Effects on the Phage and Fluoroquinolone Sensitivity in Pseudomonas aeruginosa.
Nakamura K; Fujiki J; Nakamura T; Furusawa T; Gondaira S; Usui M; Higuchi H; Tamura Y; Iwano H
Virus Res; 2021 Dec; 306():198596. PubMed ID: 34648885
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosa.
Ng RN; Grey LJ; Vaitekenas A; McLean SA; Rudrum JD; Laucirica DR; Poh MW; Hillas J; Winslow SG; Iszatt JJ; Iosifidis T; Tai AS; Agudelo-Romero P; Chang BJ; Stick SM; Kicic A;
J Microbiol Methods; 2021 Nov; 190():106346. PubMed ID: 34637818
[TBL] [Abstract][Full Text] [Related]
13. Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics.
Samananda Singh L
Biologicals; 2024 Feb; 85():101725. PubMed ID: 37951140
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage therapy as a treatment strategy for orthopaedic-device-related infections: where do we stand?
Onsea J; Wagemans J; Pirnay JP; Di Luca M; Gonzalez-Moreno M; Lavigne R; Trampuz A; Moriarty TF; Metsemakers WJ
Eur Cell Mater; 2020 May; 39():193-210. PubMed ID: 32368785
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
Squires RA
N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
[TBL] [Abstract][Full Text] [Related]
16. Towards Inhaled Phage Therapy in Western Europe.
Wienhold SM; Lienau J; Witzenrath M
Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriophage Therapy: Retrospective Review and Future Prospects].
Tian EK; Wang Y; Wu ZX; Wan ZQ; Cheng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):170-175. PubMed ID: 33829687
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
Oechslin F; Piccardi P; Mancini S; Gabard J; Moreillon P; Entenza JM; Resch G; Que YA
J Infect Dis; 2017 Mar; 215(5):703-712. PubMed ID: 28007922
[TBL] [Abstract][Full Text] [Related]
19. Phage Therapy for Respiratory Infections: Opportunities and Challenges.
Khosravi A; Chen Q; Echterhof A; Koff JL; Bollyky PL
Lung; 2024 Jun; 202(3):223-232. PubMed ID: 38772946
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophage therapy in implant-related infections: an experimental study.
Yilmaz C; Colak M; Yilmaz BC; Ersoz G; Kutateladze M; Gozlugol M
J Bone Joint Surg Am; 2013 Jan; 95(2):117-25. PubMed ID: 23324958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
